Adherence, Medication, Chronic Kidney Diseases
Conditions
Brief summary
The aim of the study is to assess the impact of pharmacist led mobile application on adherence and efficacy of medication in chronic kidney disease patients
Detailed description
This is a prospective randomized two group pharmacist-led interventional study that will be conducted in a private nephrology clinic. The study will involve introduction of the mobile phone applications to chronic kidney disease patients to improve their adherence to the prescribed medications. Recruited patients will be randomly divided in two groups; intervention group and control group, with baseline evaluation of outcomes to be measured. Control group will be provided with usual care. Intervention group will be provided in addition to the usual care, with an access to the mobile application after a simple training for app usage. Both groups will be followed for a period of 3 months. The study will include the development, validation and the testing for evaluating the specially designed mobile application.
Interventions
OTHERMobile Application
mobile phone applications directed to chronic kidney disease patients to improve their medication.
Sponsors
Cairo University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Stages 2-5 of chronic kidney disease * Literate * Ownership of android smart phone compatible with the application * Poly-pharmacy
Exclusion criteria
* On dialysis due to loss of kidney function * Pregnancy due to altered physiology
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in medication adherence | Change from baseline at 3 months | Using a medication adherence questionnaire. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in estimated glomerular filtration rate/ creatinine clearance | Change from baseline at 3 months | Calculated using serum creatinine lab results obtained from clinic. |
| Change in systolic and diastolic blood pressure | Change from baseline at 3 months | To be measured in clinic. |
| Change in HbA1c | Change from baseline at 3 months | Lab results obtained from clinic. |
| Change in mobile application usability and acceptability by patients | Change from baseline at 3 months | Using System Usability Scale (SUS) questionnaire. (scale 0-100 with higher score meaning better usability) |
Countries
Egypt
Outcome results
None listed